Instructions for Novobismol pills
English product name
Novobismol
Release form
tab, film coating, 120 mg:
Description Novobismol:
The tablets are covered with a film shell of cream-white color, round, double-convex, odorless or with a slight smell of ammonia.
1 tab.
bismuth tripotassium dicitrate 304.6 mg,
which corresponds to the content of bismuth oxide 120 mg
Auxiliary substances: cornstarch, potassium polyacrylate, povidon K30, macrogol 6000, magnesium stearate.
Shell Composition:
Opadray OY-S-7366 (5mPa·s hypomellose, 6000 macrogol).
ATC codes
A02BX05 Bismuth subcitrate
Clinical-pharmacological groups / Group affiliation
Preparation having a protective effect on the mucosa of the stomach and duodenum. Antiulcer preparation
Active substance Novobismol
bismuth tripotassium dicitrate
Pharmacotherapy group:
Antiseptic intestinal and astringent agent
Storage Conditions
The drug Novobismol should be stored in a place inaccessible to children, dry, protected from light at a temperature not higher than 25 ° C.
Best before date
Shelf life is 4 years.
Testimony:
- Gastric and duodenal ulcer in the acute phase, including Helicobacter pylori;
- chronic gastritis and gastroduodenitis in the exacerbation phase,
- including associated with Helicobacter pylori;
- functional dyspepsia not related to organic diseases of the gastrointestinal tract;
- Irritable bowel syndrome, which occurs mainly with diarrhoea symptoms.
Method of use, course and dosage Novobismol:
The tablets must be washed with a small amount of water.
Adults and children over 12 years of age are presc:
ibed 1 tab. 3 times/day for 30 minutes before meals and 1 tab per night or 2 tab. 2 times/day for 30 minutes before meals.
Children between 8 and 12 years of age are prescribed 1 tab. 2 times/day for 30 minutes before meals; Children aged 4 to 8 years 8 mg/kg/day the daily dose is divided into 2 doses, taken 30 minutes before the meal.
The duration of treatment is 4-8 weeks. Do not use bismuth-containing medication for the next 8 weeks. For the eradication of Helicobacter pylori, it is expedient to use the bismuth of dicitrate tripotassium in combination with other antibacterial agents having anti-helicobacter activity.
Application for kidney disorders Novobismol
The use of the preparation is contraindicated in cases of pronounced kidney dysfunctions.
Use in children
The use of the preparation in children under 4 years of age is contraindicated.
- Nosology Novobismol (ICD codes)
- K25
- Stomach ulcer
- K26
- Duodenum ulcer
- K27
- Peptic ulcer
- K29
- Gastritis and duodenitis
- K30
- Functional dyspepsia (digestive disorder)
- K58.0
- Irritable bowel syndrome with diarrhea
Pharmacological effect Novobismol:
Antiulcer agent with bactericidal activity with respect to Helicobacter pylori. It also has anti-inflammatory and astringent effects.
Insoluble bismuth oxychloride and citrate are deposited in the acidic environment of the stomach, chelate compounds with the protein substrate are formed in the form of a protective film on the surface of ulcers and erosion. By increasing prostaglandin E synthesis, mucus formation and hydrocarbonate secretion, it stimulates the activity of cytoprotective mechanisms, and increases the resistance of the mucous membrane of the gastrointestinal tract to the action of pepsin, hydrochloric acid, enzymes and bile acid salts. It results in the accumulation of epidermal growth factor in the defect area. Reduces pepsin and pepsinogen activity.